also breaking this morning, signs that the labor market, which has been stunningly strong for so long is now cooling. fed watchers and wall street very warily awaiting these numbers. i ll talk to acting labor secretary julie su for her take on the numbers and the strength of the u.s. economy. and later, more heat for an already weather-weary nation. over a dozen dead nationwide from the high temperatures. i have asthma, so the air quality is really hard on my lungs, and then with the heat on top, it s like having a meltdown all in one. when could we get some relief from the brutal and record-breaking heat? let s begin with the war in ukraine and the breaking news. we ve now confirmed that the u.s. will send cluster munitions to ukraine. these are large bombs containing smaller explosives inside them which then disperse and can kill in record numbers. these weapons are so dangerous that more than 120 countries including many u.s. allies have agreed not to use them, but
august. alzheimer s threw us for a loop, this drug has thrown us a lifeline. that was nbc s kate snow reporting. back with us now, dr. vin gupta. doctor, this drug s approval is encouraging news for people with alzheimer s and their families, but it isn t a cure, right? it just slows it down. so how much of a difference will people see? ana, that s the critical question. this is a milestone. this is a fist step towards new therapeutics to the point that kate made in her segment here. this is going to allow those with early stage alzheimer s to have an independent life for a longer period of time. is it a cure? no. we have to have clear understanding of what outcomes this is going to improve. when it comes to independent functioning, communication abilities, meaningful time with family, this is going to increase all those things that are important to patients. just for people who have the mild at least start of the disease. the drug s approval came with the fda s strongest saf